Combinatorial nanoparticles for cancer diagnosis and therapy

Area of Science:

• Biotechnology and Nanotechnology
• Nanomedicine and Cancer Therapy

Background:

• Nanotechnology and biotechnology integration offers novel solutions for drug delivery, medical imaging, and biosensing.
• Conjugating nanoparticles with biomolecules like QD-herceptin and QD-aptamer-DOX conjugates addresses challenges in cancer diagnosis and therapy.

Purpose of the Study:

• To review combinatorial nanoparticles designed for cancer imaging and therapy.
• To classify these nanoparticles into inorganic, polymeric, and liposome-based nanosystems.

Main Methods:

• Review of existing literature on combinatorial nanoparticles for cancer applications.
• Classification of nanoparticles based on their composition (inorganic, polymeric, liposomes).

Main Results:

• Identified inorganic nanoparticles (quantum dots, iron oxide, gold, silica, carbon), polymeric nanoparticles (PLGA, PLGA-PEG, PAMAM), liposomes, and lipid nanoparticles.
• Highlighted the multifunctional nature of these nanoparticles, combining targeting, imaging, and therapeutic capabilities.

Conclusions:

• Combinatorial nanoparticles represent a promising strategy for advancing cancer diagnosis and therapy.
• The classification into inorganic, polymeric, and liposome-based systems provides a framework for understanding their applications.